These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 36497490)

  • 1. Cytoreductive Surgery (CRS) and HIPEC for Advanced Ovarian Cancer with Peritoneal Metastases: Italian PSM Oncoteam Evidence and Study Purposes.
    Marrelli D; Ansaloni L; Federici O; Asero S; Carbone L; Marano L; Baiocchi G; Vaira M; Coccolini F; Di Giorgio A; Framarini M; Gelmini R; Palopoli C; Accarpio F; Fagotti A
    Cancers (Basel); 2022 Dec; 14(23):. PubMed ID: 36497490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laparoscopic Cytoreduction Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Peritoneal Surface Malignancies (PSM): Italian PSM Oncoteam Evidence and Literature Review.
    Sommariva A; Valle M; Gelmini R; Tonello M; Carboni F; De Manzoni G; Sorrentino L; Pasqual EM; Bacchetti S; Sassaroli C; Di Giorgio A; Framarini M; Marrelli D; Casella F; Federici O
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indications for hyperthermic intraperitoneal chemotherapy with cytoreductive surgery: a clinical practice guideline.
    Auer RC; Sivajohanathan D; Biagi J; Conner J; Kennedy E; May T
    Curr Oncol; 2020 Jun; 27(3):146-154. PubMed ID: 32669924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperthermic Intraperitoneal Chemotherapy for Ovarian and Colorectal Cancer: A Review.
    van Stein RM; Aalbers AGJ; Sonke GS; van Driel WJ
    JAMA Oncol; 2021 Aug; 7(8):1231-1238. PubMed ID: 33956063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indications for hyperthermic intraperitoneal chemotherapy with cytoreductive surgery: a systematic review.
    Auer RC; Sivajohanathan D; Biagi J; Conner J; Kennedy E; May T
    Eur J Cancer; 2020 Mar; 127():76-95. PubMed ID: 31986452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer with Synchronous Peritoneal Metastases: Multicenter Study of 'Italian Peritoneal Surface Malignancies Oncoteam-S.I.C.O.'.
    Marano L; Marrelli D; Sammartino P; Biacchi D; Graziosi L; Marino E; Coccolini F; Fugazzola P; Valle M; Federici O; Baratti D; Deraco M; Di Giorgio A; Macrì A; Pasqual EM; Framarini M; Vaira M; Roviello F;
    Ann Surg Oncol; 2021 Dec; 28(13):9060-9070. PubMed ID: 34057569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer: A Review.
    Bhatt A; Glehen O
    Indian J Surg Oncol; 2016 Jun; 7(2):188-97. PubMed ID: 27065709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short and long-term outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for colorectal and appendiceal cancer peritoneal metastasis: Propensity score-matched comparison between laparoscopy vs. open approaches.
    Chang SC; Fingerhut A; Chen WT
    Surg Oncol; 2022 Aug; 43():101766. PubMed ID: 35430126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial Experience of Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Baltic Country Center.
    Račkauskas R; Baušys A; Jurgaitis J; Paškonis M; Strupas K
    J Clin Med; 2022 Sep; 11(19):. PubMed ID: 36233421
    [No Abstract]   [Full Text] [Related]  

  • 10. Hyperthermic intraperitoneal chemotherapy (HIPEC) for the management of primary advanced and recurrent ovarian cancer: a systematic review and meta-analysis of randomized trials.
    Filis P; Mauri D; Markozannes G; Tolia M; Filis N; Tsilidis K
    ESMO Open; 2022 Oct; 7(5):100586. PubMed ID: 36116421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Clinician's perspective on the role of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer management.
    Ostrowski T; Litwiński J; Gęca K; Świetlicka I; Polkowski WP; Skórzewska M
    Surg Oncol; 2024 Oct; 56():102117. PubMed ID: 39096575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel treatment protocol with 6 cycles of neoadjuvant chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in stage III primary ovarian cancer.
    Marrelli D; Petrioli R; Cassetti D; D'Ignazio A; Marsili S; Mazzei MA; Lazzi S; Roviello F
    Surg Oncol; 2021 Jun; 37():101523. PubMed ID: 33545658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival After Hyperthermic Intraperitoneal Chemotherapy and Primary or Interval Cytoreductive Surgery in Ovarian Cancer: A Randomized Clinical Trial.
    Lim MC; Chang SJ; Park B; Yoo HJ; Yoo CW; Nam BH; Park SY;
    JAMA Surg; 2022 May; 157(5):374-383. PubMed ID: 35262624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoreduction (Peritonectomy Procedures) Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Advanced Ovarian Cancer: Retrospective Italian Multicenter Observational Study of 511 Cases.
    Di Giorgio A; De Iaco P; De Simone M; Garofalo A; Scambia G; Pinna AD; Verdecchia GM; Ansaloni L; Macrì A; Cappellini P; Ceriani V; Giorda G; Biacchi D; Vaira M; Valle M; Sammartino P
    Ann Surg Oncol; 2017 Apr; 24(4):914-922. PubMed ID: 27896512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of ovarian metastases of colorectal and appendiceal carcinoma in the era of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Kuijpers AM; Mehta AM; Aalbers AG; van Driel WJ; Boot H; Verwaal VJ
    Eur J Surg Oncol; 2014 Aug; 40(8):937-42. PubMed ID: 24630923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastasis from breast cancer: a preliminary report of 4 cases.
    Yu JH; Feng Y; Li XB; Zhang CY; Shi F; An SL; Liu G; Zhang YB; Zhang K; Ji ZH; Li B; Yan GJ; Li YP; Li Y
    Gland Surg; 2021 Apr; 10(4):1315-1324. PubMed ID: 33968683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct surgery with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for patients with colorectal peritoneal metastases.
    Ljunggren M; Nordenvall C; Palmer G
    Eur J Surg Oncol; 2021 Nov; 47(11):2865-2872. PubMed ID: 34116900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) with primary or secondary cytoreductive surgery in the treatment of advanced epithelial ovarian cancer.
    Manzanedo I; Pereira F; Pérez-Viejo E; Serrano Á; Hernández-García M; Martínez-Torres B; Rihuete-Caro C; Calzas J; Cueto M
    Minerva Ginecol; 2017 Apr; 69(2):119-127. PubMed ID: 27415829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of ovarian metastases on survival in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancy originating from appendiceal and colorectal cancer.
    Bignell MB; Mehta AM; Alves S; Chandrakumaran K; Dayal SP; Mohamed F; Cecil TD; Moran BJ
    Colorectal Dis; 2018 Aug; 20(8):704-710. PubMed ID: 29502336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of recurrence in women with advanced and recurrent epithelial ovarian cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Chambers LM; Yao M; Morton M; Gruner M; Chichura A; Horowitz M; Costales AB; Rose PG; Michener CM; Debernardo R
    Gynecol Oncol; 2021 May; 161(2):389-395. PubMed ID: 33551202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.